Top compounds associated with response to PRAMEF18


Feature Type Standardized
Nominal ANOVA
mRNA BRD6340 CTRPv2 pan-cancer AAC 0.027 0.4
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.028 0.4
mRNA ifosfamide CTRPv2 pan-cancer AAC 0.041 0.4
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.4
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA GSK1059615 CTRPv2 pan-cancer AAC -0.034 0.4
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA vorapaxar CTRPv2 pan-cancer AAC -0.028 0.4
mRNA VER-155008 CTRPv2 pan-cancer AAC 0.027 0.4
Download CSV